|
|||||
|
|
Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease |
|
| Authors: | Ismail Kocyigit Tevfik Ecder |
| Affiliation: | 1. Department of Internal Medicine, Division of Nephrology, Erciyes University School of Medicine, Kayseri, Turkey;2. Department of Internal Medicine, Division of Nephrology, Istanbul Bilim University School of Medicine, Istanbul, Turkey |
| Abstract: | |
| Keywords: | Nebivolol polycystic kidney disease hypertension endothelial dysfunction |